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Inflammatory Markers in Bicuspid Transcatheter Aortic Valve Replacement
Pantelic M.N., MS2, Nona P., MD, Wang D., MD.
Background
Aortic stenosis (AS) has a prevalence of 2%. Valve replacement is the definitive
treatment for AS, with transcatheter aortic valve replacement (TAVR) offering a
minimally invasive alternative to surgery.
Bicuspid aortic valve (BAV) is the most common congenital cardiac abnormality. BAV
patients are predisposed to AS, and comprise a distinct, younger TAVR patient
population. Given limited prior work on inflammatory markers for TAVR risk
assessment, this study sought to investigate if white blood cell count (WBC) correlates
with BAV TAVR patient severity and post-TAVR outcomes.
Methods
A single-center retrospective analysis was performed on patients with BAV who
underwent TAVR from 2014 to 2018 (N=37). Patient demographics, symptomatic
severity (NYHA class) and anatomic severity: aortic valve area (AVA) and indexed
aortic valve area (AVAI) were collected. WBC prior to TAVR and post-TAVR
complications/readmissions were also collected. Correlations between WBC, patient
severity, and adverse outcomes were assessed using the Pearson and Spearman
correlation tests, two-sample t-tests, and the Wilcoxon rank sum test.
Results
A statistically significant correlation (p = .041) was found between elevated
pre-procedure WBC and patient NYHA class. No association was found between
pre-procedure WBC and AVA (p = .723), AVAI (p = .961), or adverse
outcomes/readmission post-procedure (p = .116).
Conclusions
A statistically significant correlation between pre-procedure WBC and NYHA class
demonstrates that WBC is an accurate predictor of BAV patient’s functional symptom
severity and could thus serve as a readily-accessible metric to stratify BAV TAVR
patients in pre-procedure planning. No correlation existed between WBC and anatomic
valve severity.

